113 related articles for article (PubMed ID: 24123292)
1. Design and synthesis of lipidic organoalkoxysilanes for the self-assembly of liposomal nanohybrid cerasomes with controlled drug release properties.
Liang X; Li X; Jing L; Xue P; Jiang L; Ren Q; Dai Z
Chemistry; 2013 Nov; 19(47):16113-21. PubMed ID: 24123292
[TBL] [Abstract][Full Text] [Related]
2. Redox responsive liposomal nanohybrid cerasomes for intracellular drug delivery.
Zhou G; Li L; Xing J; Jalde S; Li Y; Cai J; Chen J; Liu P; Gu N; Ji M
Colloids Surf B Biointerfaces; 2016 Dec; 148():518-525. PubMed ID: 27690240
[TBL] [Abstract][Full Text] [Related]
3. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer.
Liang X; Gao J; Jiang L; Luo J; Jing L; Li X; Jin Y; Dai Z
ACS Nano; 2015 Feb; 9(2):1280-93. PubMed ID: 25599568
[TBL] [Abstract][Full Text] [Related]
4. Stabilized magnetic cerasomes for drug delivery.
Cao Z; Yue X; Li X; Dai Z
Langmuir; 2013 Dec; 29(48):14976-83. PubMed ID: 24188471
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers.
Yue X; Dai Z
Adv Colloid Interface Sci; 2014 May; 207():32-42. PubMed ID: 24368133
[TBL] [Abstract][Full Text] [Related]
6. Stabilized liposomal nanohybrid cerasomes for drug delivery applications.
Cao Z; Ma Y; Yue X; Li S; Dai Z; Kikuchi J
Chem Commun (Camb); 2010 Aug; 46(29):5265-7. PubMed ID: 20411203
[TBL] [Abstract][Full Text] [Related]
7. Cerasomal doxorubicin with long-term storage stability and controllable sustained release.
Jin Y; Yue X; Zhang Q; Wu X; Cao Z; Dai Z
Acta Biomater; 2012 Sep; 8(9):3372-80. PubMed ID: 22659275
[TBL] [Abstract][Full Text] [Related]
8. Liposomal architecture boosts biocompatibility of nanohybrid cerasomes.
Ma Y; Dai Z; Gao Y; Cao Z; Zha Z; Yue X; Kikuchi J
Nanotoxicology; 2011 Dec; 5(4):622-35. PubMed ID: 21261456
[TBL] [Abstract][Full Text] [Related]
9. Modulation of release of paclitaxel from composite cerasomes.
Cao Z; Yue X; Jin Y; Wu X; Dai Z
Colloids Surf B Biointerfaces; 2012 Oct; 98():97-104. PubMed ID: 22659210
[TBL] [Abstract][Full Text] [Related]
10. Highly uniform and stable cerasomal microcapsule with good biocompatibility for drug delivery.
Zhang CY; Cao Z; Zhu WJ; Liu J; Jiang Q; Shuai XT
Colloids Surf B Biointerfaces; 2014 Apr; 116():327-33. PubMed ID: 24503354
[TBL] [Abstract][Full Text] [Related]
11. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of a novel organic-inorganic nanohybrid "cerasome" formed with a liposomal membrane and silicate surface.
Katagiri K; Hashizume M; Ariga K; Terashima T; Kikuchi J
Chemistry; 2007; 13(18):5272-81. PubMed ID: 17407115
[TBL] [Abstract][Full Text] [Related]
13. Photoresponsive liposomal nanohybrid cerasomes.
Liang X; Yue X; Dai Z; Kikuchi J
Chem Commun (Camb); 2011 Apr; 47(16):4751-3. PubMed ID: 21409244
[TBL] [Abstract][Full Text] [Related]
14. A novel tumor-targeted thermosensitive liposomal cerasome used for thermally controlled drug release.
Li S; Yin G; Pu X; Huang Z; Liao X; Chen X
Int J Pharm; 2019 Oct; 570():118660. PubMed ID: 31491484
[TBL] [Abstract][Full Text] [Related]
15. Lipoamino acid-based cerasomes for doxorubicin delivery: Preparation and in vitro evaluation.
Gileva A; Sarychev G; Kondrya U; Mironova M; Sapach A; Selina O; Budanova U; Burov S; Sebyakin Y; Markvicheva E
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():724-734. PubMed ID: 30948110
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols.
Mugabe C; Liggins RT; Guan D; Manisali I; Chafeeva I; Brooks DE; Heller M; Jackson JK; Burt HM
Int J Pharm; 2011 Feb; 404(1-2):238-49. PubMed ID: 21093563
[TBL] [Abstract][Full Text] [Related]
17. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
18. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.
Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ
Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
